Skip to main content
Caplight Logo









Vesalio

Vesalio

Private
Plano, TexasHealthcare & Life Scienceshttps://www.vesalio.com/

Last Round

Series A

May 18, 2022

Total Funding Raised

$5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Vesalio is a medical device company that develops and manufactures thrombectomy platforms for the removal of blood clots in the brain, heart, and peripheral anatomy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurothrombectomystroke interventionstent retrieverclot removalneurovascular deviceacute ischemic strokethrombectomymechanical thrombectomyrecanalizationneurointerventional surgerystroke center equipmentmedical device manufacturer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vesalio Comparables

Compare Vesalio with similar companies based on industry and business-model similarity.

Vesalio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RapidPulse
90%
Ceretrieve
89%
Acandis
88%

Vesalio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 18, 2022
Early FundingMay 14, 2019

Key People

Founding team and executive leadership

J.D. McCulloch

Chief Financial Officer

Executive Team

Vesalio Investors

Notable investors and investment history

Vesalio investors
InvestorRounds
Orlando Health VenturesSeries A
Solas BioVenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 33% MoM.

  • Jul 18, 2026

    Grew 21% QoQ, from 52 to 63 employees.

Recent news

Latest coverage and updates

  • hiresOct 15, 2026

    Vesalio appoints Daniel Davis to its Board of Directors and as Advisor to the CEO in Texas on Oct 15th '26, where he provides strategic guidance on product portfolio priorities and commercial growth.

  • hiresOct 15, 2026

    Vesalio appoints Daniel Davis to its Board of Directors and as Advisor to the CEO in Texas on Oct 15th '26, where he provides strategic guidance on product priorities and commercial growth.

  • launchesAug 13, 2026

    Vesalio launched pVasc NET on Aug 13th '26.

  • attends_eventJul 21, 2026

    Vesalio attended event ESC Congress 2026 on Aug 29th '26.

  • attends_eventJul 21, 2026

    Vesalio will attend event European Society of Cardiology (ESC) Congress 2026 on Aug 28th '26.

Vesalio Filings

Explore SEC and related filing metadata, where available.

Vesalio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vesalio's valuation, stock price, and market status.

Is Vesalio a public or private company?

Vesalio is a private company.

What is the current stock price of Vesalio?

Vesalio is a private company, so its shares have no public market price. Caplight tracks Vesalio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Vesalio worth (valuation)?

Valuation information for Vesalio is not publicly available.

Can I buy Vesalio stock?

Vesalio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Vesalio's last funding round?

Vesalio's most recent funding round was Series A on May 18, 2022.

Who are the main investors in Vesalio?

Key investors in Vesalio include Solas BioVentures.

Will Vesalio IPO soon?

No public IPO plans have been announced for Vesalio.

How can I track Vesalio secondary market activity?

Caplight tracks bids, offers, and trades in Vesalio's shares on secondary markets.

Firmographic Details

HeadquartersPlano, Texas
Employee Range32
Year Founded2017
Last FundingMay 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?